Automation in Biopharmaceutical Market Size, Trends, Share, Growth, and Opportunity Forecast, 2024 - 2031 Global Industry Analysis By Component (Hardware, Software, and Services), By Technology Type (Automation, and Digitization), By Application (Drug Discovery, Biopharmaceutical Production, Quality Control, Inventory Management, and Others), By End-User (Biopharmaceutical Companies, Biotech Companies, and Research Institutes) and By Geography (North America, Europe, Asia Pacific, South America, and Middle East & Africa)

The Global Automation in Biopharmaceutical Market was valued at USD 1.98 Billion in 2023 and is anticipated to reach a value of USD 3.18 Billion by 2031 expanding at a CAGR of 6.2% between 2024 and 2031.

Automation in biopharmaceuticals industry refers to the integration of advanced technologies and robotics to streamline and enhance various processes involved in pharmaceutical industry. Automation is revolutionizing the biopharmaceutical industry by optimizing workflows, reducing manual labor, minimizing time-consuming and repetitive tasks. These automated systems offer hardware, software, and services for various biopharmaceutical applications. Automation is integrated in the biopharmaceutical industry for streamlining various processes from drug discovery to manufacturing of products. It uses automated systems and technologies to carry out tasks that are performed by humans, aimed to increase efficiency, accuracy, consistency, and productivity in manufacturing biopharmaceutical products. These systems are designed to perform tasks such as drug discovery, packaging, quality control, inventory management, and distribution with improved quality and consistency.  The market for automation in biopharmaceuticals is witnessing significant growth due to factors such as technological innovations, increasing demand for biopharmaceuticals, stringent regulatory requirements, and rising role of robotics in pharmaceuticals.

To learn more about this report, request a free sample copy

Automation in Biopharmaceutical Market Major Driving Forces

Technological Innovations: Ongoing technological advancements in automation, such as the use of artificial intelligence, machine learning, and robotics are driving adoption of automation in biopharmaceutical industry. Biopharmaceutical products are becoming more complex, necessitates advanced automation to ensure high-quality and consistent production.

Increasing Demand for Biopharmaceuticals: The demand for automation in biopharmaceuticals is influenced by rising demand for biopharmaceuticals. The increasing incidences of chronic diseases and the growing need for effective treatments are driving the demand for biopharmaceutical products.  

Stringent Regulatory Requirements: The biopharmaceutical industry is subject to rigorous quality and safety regulations. Strict regulations to ensure product safety and quality drives demand for automation in these industry. Automation systems aid in compliance by providing accurate data, real-time monitoring, and documentation.

Rising Role of Robotics in Pharmaceuticals: The growing adoption of robots in pharmaceutical manufacturing is propelling the growth of automation in biopharmaceutical industry.  Robots are used in various applications pharmaceutical production, such as laboratory automation, packaging, and drug discovery.  

Automation in Biopharmaceutical Market Key Opportunities

Personalized Medicine: The growing shift towards personalized medicine is creating a huge demand for advanced automation solutions to cater individualized treatments. The rise of personalized medicine, where treatments are customized for individual patients, necessitates the production of complex and patient-specific therapies.  

Integration of Advanced Technologies: Leveraging advanced technologies such as IoT, artificial intelligence, machine learning, and robotics into biopharmaceutical manufacturing processes creates an opportunity for market expansion. These emerging technologies can further enhance automation capabilities, quality control, and consistency of biopharmaceutical manufacturing.

Accelerated Drug Development: The increasing drug development is anticipated to boost the growth of automation in the biopharmaceutical industry. The rise in drug development fuels the biopharma industry automation, where automated systems are used to streamline various processes, ensure precision, and enhance efficiency.

Automation in Biopharmaceutical Market Key Trends

·         Technological advancement is a key trend gaining popularity in the automation in biopharmaceuticals industry

·         The increasing adoption of robotics in biopharmaceutical manufacturing processes is influencing the growth of the market  

·         The rise in drug development is boosting the demand for automation in biopharmaceutical to streamline various processes

·         The growing need for equipment that lowers pharmaceutical mistakes is fueling the expansion of the automation in biopharmaceuticals industry

·         The growing use of IoT devices and automation systems enable remote monitoring and control of bioprocesses

·         The significant shift towards sustainability in the biopharmaceutical industry that focusing on waste reduction, resource conservation, and energy efficiency

·         Increased use of AI, machine learning, and robotics to enhance automation capabilities, quality control, and consistency of biopharmaceutical manufacturing

·         Advancement in single-use technologies are gaining traction due to their greater efficiency, flexibility, and cost-effectiveness  

Region-wise Market Insights

North America accounted for the largest market share at 37.8% in 2023 whereas, Asia Pacific is expected to register the fastest growth, expanding at a CAGR of 7.0% between 2024 and 2031.

To learn more about this report, request a free sample copy

North America is the largest region in the automation in biopharmaceuticals market. In North America, the demand is driven by vast investments, robust technological infrastructure, and presence of leading biopharmaceutical companies, and research institutions in the region.  This region has a strong industrial base, advanced healthcare system, and regulatory environment that encourages innovation in the biopharmaceutical industry. Europe emphasizes on product quality, creating a strong demand for automation products to ensure product quality. In Asia-Pacific, the market is characterized by strong pharmaceutical manufacturing sector, rapid economic growth, increasing prevalence of chronic diseases, and rising demand for pharmaceuticals which has created an increasing demand for automation in biopharmaceuticals. The Middle East and Africa has been witnessing a growing demand for automation in biopharmaceuticals whereas, in Latin America, the market is influenced by economic factors, with growing demand for biopharmaceutical products.

Market Competition Landscape

The global automation in biopharmaceutical market is characterized by high degree of competition among a large number of players. These major players operating in the industry are focused on developing advanced product and services to strengthen their position in the market. Key players in the automation in biopharmaceutical market engage in strategies aimed at gaining a competitive edge. These strategies include product innovation, design differentiation, and the incorporation of sustainable and eco-friendly practices to meet evolving consumer preferences. Established brands leverage their reputation for quality and reliability to maintain market share, while newer entrants focus on disruptive innovations and unique selling propositions.

Key players in the global automation in biopharmaceutical market implement various organic and inorganic strategies to strengthen and improve their market positioning. Prominent players in the market include:

·         F. Hoffmann-La Roche Ltd

·         Thermo Fisher Scientific Inc.

·         Danaher Corporation

·         ABB Ltd.

·         Siemens Healthineers AG

·         Emerson Electric Co.

·         Honeywell International Inc.

·         BD (Becton, Dickinson and Company)

·         Corning Incorporated

·         Rockwell Automation Inc.

·         Agilent Technologies Inc.

·         PerkinElmer Inc.

·         Sartorius AG

·         bioMérieux SA

·         GE Healthcare